Vaccine Immunotherapy for a Deadly Disease Like Malignant Melanoma: Where Do We Stand?*
نویسندگان
چکیده
Address correspondence to: Farid Saleh, Faculty of Medicine, Health Sciences Centre, Department of Anatomy, Kuwait University. Jabriya, P.O.Box: 24923, Safat, Kuwait, Postal Code 13110, Kuwait. Tel: 4986265, Fax: +965 5319478, E-mail: [email protected] or [email protected] Farid Saleh, Ghada Ibrahim, Hussein Dashti, Pedro Romero, Abdullah Behbehani, Hilal Al-Sayer, Sami Asfar, Ali Dashti, Waleed Renno, Suad Abdeen, Ivo Klepacek Faculty of Medicine, Health Sciences Centre, Department of Anatomy, Kuwait University, Jabriya, Kuwait Department of Surgery, Muabrak Al-Kabeer Hospital, Jabriya, Kuwait Division of Clinical Onco-Immunology, Ludwig Institute for Cancer Research, Hospital Orthopedique, Lausanne, Switzerland Faculty of Health Sciences, Kuwait University, Shuwaikh, Kuwait Department of Pathology, Kuwait University, Jabriya, Kuwait
منابع مشابه
Novel anti-melanoma treatment: focus on immunotherapy
Melanoma is an intractable cancer that is aggressive, lethal, and metastatic. The prognosis of advanced melanoma is very poor because it is insensitive to chemotherapy and radiotherapy. The incidence of melanoma has been ascending stably for years worldwide, accompanied by increasing mortality. New approaches to managing this deadly disease are much anticipated to enhance the cure rate and to e...
متن کاملPigmented Bowens disease mimicking malignant Melanoma: A case report
Pigmented Bowens disease is an in situ squamous cell carcinoma, which is seldom reported in white patients. Herein we report a 20-year-old woman with type III skin, who had this lesion on the fourth finger of her right hand, similar to superficial malignant melanoma, clinically. Although dermoscopic evaluation could be helpful, correct diagnosis of non-melanotic origin is done by histological e...
متن کاملAlphavirus Replicon Particles Expressing TRP-2 Provide Potent Therapeutic Effect on Melanoma through Activation of Humoral and Cellular Immunity
BACKGROUND Malignant melanoma is the deadliest form of skin cancer and is refractory to conventional chemotherapy and radiotherapy. Therefore alternative approaches to treat this disease, such as immunotherapy, are needed. Melanoma vaccine design has mainly focused on targeting CD8+ T cells. Activation of effector CD8+ T cells has been achieved in patients, but provided limited clinical benefit...
متن کاملMolecular biology of human melanoma development and progression.
In the United States, Australia, Northern Europe, and Canada, malignant melanoma is increasing at a faster rate than any other cancer, with the exception of lung cancer in women. Major advances have been made in the molecular biology and immunology of melanoma. These advances in basic science have led to more rational approaches to specifically targeting melanoma cells, with promising results i...
متن کاملMalignant melanoma--future prospects.
As the incidence and already high mortality rates of malignant melanoma have been steadily increasing in recent decades, the early detection and excision of malignant melanoma have imposed as the most important task. Staging of malignant melanoma is determined according to the level of invasion (Clark level) and vertical thickness (Breslow scale). Besides operative therapy, which is the only ef...
متن کامل